Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.2 is now displayed and Revision: v3.2.0 is no longer shown. This is a routine metadata update and does not affect the study details.SummaryDifference0.0%

- Check20 days agoChange DetectedThe government funding transparency notice about updates and operating status has been removed. No study details, eligibility criteria, or planned outcomes were changed.SummaryDifference0.2%

- Check41 days agoChange DetectedNo significant changes detected; the study details, enrollment, locations, and primary/secondary outcomes appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check55 days agoChange DetectedRemoved a MedlinePlus Genetics topic on Schizophrenia; overall page content in the genetics/health topic area is reduced.SummaryDifference0.2%

- Check63 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check70 days agoChange DetectedPage version updated to v3.1.0 with a new MedlinePlus Genetics topic on Schizophrenia; previous version v3.0.2 removed.SummaryDifference0.3%

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.